Oral administration of the dopamine prodrug docarpamine shortens need for drip infusion of dopamine in patients with low cardiac output syndrome after cardiac surgery
K. Matsubayashi et al., Oral administration of the dopamine prodrug docarpamine shortens need for drip infusion of dopamine in patients with low cardiac output syndrome after cardiac surgery, THOR CARD S, 47(6), 1999, pp. 352-356
Background: Docarpamine (DOC) is a dopamine prodrug which can be orally adm
inistered. It has been found that oral docarpamine transforms into dopamine
in vivo, and increases cardiac output and renal blood flow as effectively
as intravenous dopamine. Methods: We reviewed the records of 26 patients wh
o had developed low cardiac output syndrome (LOS) after cardiac surgery and
received docarpamine during the early postoperative course. Five patients
discontinued docarpamine within 2 days due to arrhythmia. There were 3 hosp
ital deaths. The remaining 18 patients were divided into two groups accordi
ng to the timing of docarpamine administration. In group A docarpamine was
administered during and after weaning from intravenous catecholamines, in g
roup B only on demand after weaning from intravenous catecholamines. Result
s: There were 12 patients in group A and 6 in group B, and the severity of
LOS was relatively milder in group B than in group A. Stable hemodynamics a
nd sufficient daily urinary output were maintained by oral administration o
f DOC in both groups just as well as by drip infusion of catecholamines. Co
nclusion: Sinse continuous drip infusion of catecholamine commonly slows re
covery in LOS patients, it is considered that switching from drip infusion
of catecholamines to oral DOC administration is safe and useful for earlier
recovery in LOS patients after cardiac surgery.